The fight against Hepatitis C virus (HCV) has been significantly bolstered by the advent of directly acting antivirals (DAAs) like Daclatasvir. These groundbreaking medications have revolutionized treatment, offering higher cure rates and improved patient outcomes. However, the efficacy of Daclatasvir hinges on the quality and consistent availability of its essential building blocks – pharmaceutical intermediates. Among these, tert-Butyl (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylate (CAS: 1007882-12-3) stands out as a crucial component.

For pharmaceutical manufacturers and procurement managers, sourcing this intermediate demands a focus on purity, reliability, and cost-effectiveness. As a dedicated pharmaceutical intermediate manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. understands these critical requirements. We specialize in producing tert-Butyl (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylate with an impressive assay of ≥98.0%. This high level of purity is not merely a specification; it is a guarantee of consistent performance in the complex synthesis of Daclatasvir, ensuring that the final active pharmaceutical ingredient (API) meets stringent global standards.

The chemical structure of this intermediate, featuring a boronic ester and an imidazole ring, makes it a versatile reagent in organic synthesis. While its primary application is in the production of Daclatasvir, its unique chemical properties also lend themselves to broader research and development in the pharmaceutical sector. For companies looking to buy tert-Butyl (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, choosing a reputable supplier is paramount. Our commitment extends beyond simple product delivery; we aim to be a strategic partner, ensuring a stable supply chain that supports uninterrupted production schedules.

The global demand for effective HCV treatments means that the need for high-quality intermediates like ours will continue to grow. By partnering with NINGBO INNO PHARMCHEM CO.,LTD., you gain access to a reliable source for this essential Daclatasvir intermediate. We offer competitive prices and flexible packaging solutions to meet diverse procurement needs, whether for R&D laboratories or large-scale commercial production. Exploring the price market for this intermediate reveals the importance of working with manufacturers who can balance quality with affordability. We are confident in our ability to provide both, making us your ideal choice for sourcing this critical pharmaceutical component. If you are seeking a dependable manufacturer or supplier for this key intermediate, we encourage you to contact us to discuss your requirements and secure a sample.